Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries

Respiratory syncytial virus (RSV) infection occurs commonly in infants aged ≤2 years, and severe infection results in hospitalization with accompanying morbidity and mortality. Palivizumab has been available for prophylaxis for the past 15 years. Prospective data on patients who received palivizumab...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Paes, Bosco, Mitchell, Ian, Li, Abby, Harimoto, Tetsuhiro, Lanctôt, Krista L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3703731/
https://ncbi.nlm.nih.gov/pubmed/23861694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/917068
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak